Abram Elsenraat, MD
Pain Medicine · Columbia, MONPI 1043357452
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (50.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 34.3% of the total. Reporting peaked in 2024 at $10,140 and has fallen 61.5% since, to $3,903 in 2025.
Across 78 payments — averaging $182.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$4K
- Abbott$4K
- Saluda Medical Americas, Inc.$311
- Globus Medical$291
- SPR Therapeutics, Inc$170
- plus $434 from 8 others
What the payments were for
- Grants$7,25051%
- Travel & lodging$2,16115%
- Food & beverage$4,85634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $4,896 |
| Boston Scientific | 14 | $4,146 |
| Abbott | 16 | $4,018 |
| Saluda Medical Americas, Inc. | 2 | $311 |
| Globus Medical | 3 | $291 |
| SPR Therapeutics, Inc | 2 | $170 |
| MML US, Inc. | 2 | $123 |
| Merck | 5 | $88 |
| Nalu Medical, Inc. | 1 | $70 |
| Abiomed | 1 | $58 |
| Eagle Pharmaceuticals, Inc. | 2 | $31 |
| Fisher & Paykel Healthcare Inc | 1 | $26 |
| Vertex | 1 | $26 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WaveWriter Alpha Prime 16$2,611
- SYNCHROMEDII$2,500
- INTELLIS ADAPTIVESTIM$1,072
- PROCLAIM$906
- Intracept$546
- ETERNA$449
- INCEPTIV$341
- Evoke$311
- Senza$255
- KYPHON EXPRESS II KYPHOPAK TRAY$175
- SPRINT PNS System$129
- ReActiv8$110
How this compares
$14,266 in reported general payments places this provider in the 85th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 107 | $2,027 |
| Duloxetine Hcl | 37 | $1,328 |
| Baclofen | 58 | $1,158 |
| Celecoxib | 15 | $534 |
| Diclofenac Sodium | 20 | $526 |
| Methocarbamol | 35 | $484 |
| Tizanidine Hcl | 34 | $434 |
| Cyclobenzaprine Hcl | 19 | $395 |
| Pregabalin | 18 | $286 |
| Nortriptyline Hcl | 15 | $188 |
| Meloxicam | 16 | $28 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Columbia
- Ebby VargheseColumbia$8K
- Donald MeyerColumbia$8K
- Shady Adib KelehColumbia$7K
- Richard WolkowitzColumbia$3K
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.